Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies
Nanthip Prathumsap, Krekwit Shinlapawittayatorn, Siriporn C. Chattipakorn, et al.
European Journal of Pharmacology (2019) Vol. 866, pp. 172818-172818
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis
Renyikun Yuan, Wentong Zhao, Qinqin Wang, et al.
Pharmacological Research (2021) Vol. 170, pp. 105748-105748
Open Access | Times Cited: 183
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors
Mohamed S. Dabour, Mina Y. George, Mary R. Daniel, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 159-182
Open Access | Times Cited: 15
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 349-349
Open Access | Times Cited: 91
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 83
Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy
Muhammad Sohail, Zheng Sun, Yanli Li, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 12, pp. 1385-1398
Closed Access | Times Cited: 64
Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
Leonardo Schirone, Luca D’Ambrosio, Maurizio Forte, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2000-2000
Open Access | Times Cited: 54
Brightline-1: phase II/III trial of the MDM2–p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS
Patrick Schöffski, Mehdi Lahmar, Anthony Lucarelli, et al.
Future Oncology (2023) Vol. 19, Iss. 9, pp. 621-629
Open Access | Times Cited: 26
Recent advances and futuristic potentials of nano-tailored doxorubicin for prostate cancer therapy
Rana Sawpari, Sovan Samanta, Jhimli Banerjee, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104212-104212
Closed Access | Times Cited: 21
Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside
Márta Sárközy, Zoltán Varga, Renáta Gáspár, et al.
Clinical Research in Cardiology (2021) Vol. 110, Iss. 4, pp. 507-531
Open Access | Times Cited: 46
Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation
Lei Zhang, Cundong Fan, Huachen Jiao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 32
Unveiling the potential anticancer activity of Spirulina maxima extract-nanoemulsion through in vitro and in vivo studies
Mona Hussein, Mohamed Nasr, Veronia Emad, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
NADPH Oxidases in Cancer Therapy-Induced Cardiotoxicity: Mechanisms and Therapeutic Approaches
Ayat Hussein Adhab, Farag M. A. Altalbawy, Morug Salih Mahdi, et al.
Cardiovascular Toxicology (2025)
Closed Access
Apocynum venetum leaf extract alleviated doxorubicin-induced cardiotoxicity through the AKT/Bcl-2 signaling pathway
Yang Zhang, Shan Liu, Jiulong Ma, et al.
Phytomedicine (2021) Vol. 94, pp. 153815-153815
Closed Access | Times Cited: 38
Role of Inflammation and Redox Status on Doxorubicin-Induced Cardiotoxicity in Infant and Adult CD-1 Male Mice
Ana Reis-Mendes, Ana Isabel Padrão, José Alberto Duarte, et al.
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1725-1725
Open Access | Times Cited: 34
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
Ying Liu, Xiang Ao, Guoqiang Ji, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
In vivoandin vitroprotective effects of shengmai injection against doxorubicin-induced cardiotoxicity
Peng Zhou, Ge Gao, Chunchun Zhao, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 638-651
Open Access | Times Cited: 24
Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3
Jingmei Zhang, Weili Li, Siming Xue, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117134-117134
Closed Access | Times Cited: 13
Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy
Ashot Avagimyan, Mohammad Sheibani, Nana Pogosova, et al.
International Journal of Cardiology (2023) Vol. 391, pp. 131331-131331
Closed Access | Times Cited: 12
Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity
Xuan Zhang, Chaoming Huang, Yanhong Hou, et al.
Phytomedicine (2024) Vol. 129, pp. 155673-155673
Closed Access | Times Cited: 4
Mechanistic study of Huangqi Guizhi Wuwu decoction amelioration of doxorubicin-induced cardiotoxicity by reducing oxidative stress and inhibiting cellular pyroptosis
Yu Chen, Meng Xu, Xiaomei Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116653-116653
Open Access | Times Cited: 4
NSUN2 alleviates doxorubicin-induced myocardial injury through Nrf2-mediated antioxidant stress
Yi Wang, Yuxin Zan, Ying‐Ying Huang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Physiological functions of calcium signaling via Orai1 in cancer
Masanari Umemura, Rina Nakakaji, Yoshihiro Ishikawa
The Journal of Physiological Sciences (2023) Vol. 73, Iss. 1
Open Access | Times Cited: 10
Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches
Linghua Song, Qingzhuo Qiu, Fei Ju, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110140-110140
Closed Access | Times Cited: 3
Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms
Sisi Wu, Jie Lan, Lingyu Li, et al.
Cell Biology and Toxicology (2021) Vol. 39, Iss. 1, pp. 237-258
Open Access | Times Cited: 26
Polyphenolic-Rich Compounds From Dillenia pentagyna (Roxb.) Attenuates the Doxorubicin-Induced Cardiotoxicity: A High-Frequency Ultrasonography Assisted Approach
Kalyani Tene, M. Kalyan Kumar, G. Basveshwar, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top